Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid).

Author: CavaliereH, FlorianoI, Medeiros-NetoG

Paper Details 
Original Abstract of the Article :
This placebo-controlled open study was designed to test the hypothesis that most of the gastrointestinal (GI) side events induced by treatment of obese patients with orlistat (a gastrointestinal lipase inhibitor) could be prevented or ameliorated by concomitant use of natural fibers (psyllium mucill...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/sj.ijo.0801645

データ提供:米国国立医学図書館(NLM)

Preventing Gastrointestinal Side Effects of Orlistat with Natural Fibers

This research explores the potential for natural fibers, specifically psyllium mucilloid, to mitigate the gastrointestinal (GI) side effects associated with orlistat, a gastrointestinal lipase inhibitor commonly used for weight management. The study investigated the effects of concomitant use of psyllium mucilloid on GI side events in obese patients undergoing orlistat treatment.

Psyllium Mucilloid: A Potential Solution for GI Side Effects

The study suggests that concomitant prescription of psyllium mucilloid could effectively prevent or alleviate most of the GI side effects induced by orlistat treatment. This finding offers a promising approach for improving the tolerability of orlistat therapy, potentially increasing patient adherence and improving treatment outcomes.

The Importance of Addressing GI Side Effects in Weight Management

This study highlights the importance of addressing GI side effects in weight management strategies, particularly when using medications such as orlistat. It's like navigating a desert landscape with treacherous sandstorms, requiring strategies to mitigate the potential for discomfort and ensure a smoother journey towards achieving weight loss goals.

Dr.Camel's Conclusion

This study suggests a potential solution for mitigating the GI side effects associated with orlistat therapy, offering a more comfortable and tolerable weight management approach for patients. It's like discovering a hidden oasis in the desert of weight management research, providing a refreshing and effective way to minimize the challenges of GI side effects.

Date :
  1. Date Completed 2001-12-13
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

11443512

DOI: Digital Object Identifier

10.1038/sj.ijo.0801645

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.